newsThe US Food and Drug Administration (FDA) approves vosoritide injection…
23 November 2021 | By Anna Begley (European Pharmaceutical Review)
The US Food and Drug Administration (FDA) approves vosoritide injection to improve growth in children at least five years of age with achondroplasia and open epiphyses.